astragaloside a has been researched along with notoginsenoside r1 in 2 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (notoginsenoside r1) | Trials (notoginsenoside r1) | Recent Studies (post-2010) (notoginsenoside r1) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 174 | 1 | 130 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Chen, QF; Chen, YY; Fan, JY; Han, JY; He, B; He, K; Li, Q; Liu, YY; Lv, AP; Pan, CS; Sun, K; Wang, CS; Yan, L | 1 |
| Deng, BX; Deng, CQ; Ding, H; Huang, XP; Lu, JD; Tang, YH | 1 |
2 other study(ies) available for astragaloside a and notoginsenoside r1
| Article | Year |
|---|---|
QiShenYiQi Pills, a compound in Chinese medicine, protects against pressure overload-induced cardiac hypertrophy through a multi-component and multi-target mode.
Topics: Animals; Cardiomegaly; Drugs, Chinese Herbal; Energy Metabolism; Gene Expression Regulation; Ginsenosides; Heart; Myocardium; Oxidative Stress; Pressure; Proteomics; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes | 2015 |
Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Topics: Animals; Apoptosis; Astragalus Plant; Brain Ischemia; CA1 Region, Hippocampal; Cell Survival; Disease Models, Animal; Drug Combinations; Endoplasmic Reticulum Chaperone BiP; Ginsenosides; Inflammation; Janus Kinase 1; Male; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; NF-kappa B; Panax notoginseng; Phytotherapy; Reperfusion Injury; Saponins; STAT1 Transcription Factor; Triterpenes | 2015 |